Clinical Research Councillor

Andrew T. Chan, MD, MPH, AGAF

Dr. Chan received his ScB from Brown University, medical degree from Harvard Medical School, and master of public health from the Harvard T. H. Chan School of Public Health (HSPH). He did his internal medicine residency and chief residency, followed by gastroenterology fellowship at Massachusetts General Hospital (MGH), where he remains on faculty. He is professor of medicine at HMS, professor of immunology and infectious diseases at HSPH, chief of the clinical and translational epidemiology unit at MGH and the director of epidemiology at the MGH Cancer Center. He is the former program director of the MGH GI Fellowship Program. Dr. Chan is a gastroenterologist and a leading investigator in cancer prevention, supported as an Outstanding Investigator of the National Cancer Institute, Team Leader for the Stand Up to Cancer Gastric Cancer Interception Team, and by grants from the National Institute for Diabetes and Digestive and Kidney Diseases and the National Institute on Aging.

An elected member of the American Society for Clinical Investigation and the Association of American Physicians, he has published over 500 papers in the field of colorectal cancer and other chronic digestive diseases in leading journals, including the NEJM, JAMA, Lancet, Science, Nature Medicine, Gastroenterology and Gut.

Dr. Chan is a section editor for Gastroenterology, and serves on the editorial board of JNCI, Cancer Prevention Research, Cancer Epidemiology Biomarkers and Prevention. He is past chair of the Gastrointestinal Oncology Section of the AGA Institute Council, past chair of the AGA Institute Research Policy Committee, is a past member of the GRG Steering Committee and has served as a member of the AGA Institute Clinical Practice and Quality Measures Committee, Training Subcommittee, and AGA Nominating Committee. He also chairs the Molecular Epidemiology Group of the American Association for Cancer Research (AACR).